151 related articles for article (PubMed ID: 2469833)
1. [A method of isolating C1q from human serum and its use in the solid-phase immunoenzyme determination of immune complexes].
Belozerov AP
Lab Delo; 1989; (3):24-6. PubMed ID: 2469833
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
Wu CC; Bey RF; Loken KI
Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
4. Estimation of immune complexes by a microplate-adapted C1q-Protein A enzyme-linked-immunosorbent-assay (C1q-PA-ELISA).
Bjerrum L; Glikmann G; Jensenius JC; Svehag SE
J Clin Lab Immunol; 1983 Jan; 10(1):53-8. PubMed ID: 6338238
[TBL] [Abstract][Full Text] [Related]
5. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
6. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
Pearlstein E; Sorvillo J; Gigli I
J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
[TBL] [Abstract][Full Text] [Related]
7. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
8. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
[TBL] [Abstract][Full Text] [Related]
9. Assay, purification and further characterization of 7S C1q-precipitins (C1q-p) in hypocomplementemic vasculitis urticaria syndrome and systemic lupus erythematosus.
Marder RJ; Potempa LA; Jones JV; Toriumi D; Schmid FR; Gewurz H
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():25-34. PubMed ID: 6375256
[TBL] [Abstract][Full Text] [Related]
10. Characterization of C1q by monoclonal antibodies.
Heinz HP; Loos M
Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
[TBL] [Abstract][Full Text] [Related]
11. [Current situation and problems in the estimation of circulating immune complexes].
Yoshida H
Rinsho Byori; 1992 Jan; 40(1):28-33. PubMed ID: 1545522
[TBL] [Abstract][Full Text] [Related]
12. Binding characteristics of three complement dependent assays for the detection of immune complexes in human serum.
Krieger G; Kneba M; Bolz I; Volling P; Wessels J; Nagel GA
J Clin Lab Immunol; 1985 Nov; 18(3):129-34. PubMed ID: 3878887
[TBL] [Abstract][Full Text] [Related]
13. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
Kasukawa R
Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
[No Abstract] [Full Text] [Related]
14. Critical aspects of the 125I-C1q binding assay for detecting immune complexes in tumor patients.
Krieger G; Bause I; Kneba M; Kehl A; Nagel GA
J Clin Lab Immunol; 1984 Jun; 14(2):87-92. PubMed ID: 6611419
[TBL] [Abstract][Full Text] [Related]
15. The development of a C1q anti-C1q immunoadsorbent for removal of immune complexes from plasma.
Bratt T; Ohlson S
J Clin Lab Immunol; 1988 Dec; 27(4):191-5. PubMed ID: 3266946
[TBL] [Abstract][Full Text] [Related]
16. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
Heinz HP; Burger R; Golan MD; Loos M
J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
[TBL] [Abstract][Full Text] [Related]
17. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1988 Feb; 37(1):15-22. PubMed ID: 2967114
[No Abstract] [Full Text] [Related]
18. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
Casali P; Lambert PH
Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.
Valesini G; Picardo M; Pastore R; Pivetti P; Serafini U
Clin Exp Immunol; 1981 Jun; 44(3):522-7. PubMed ID: 6976862
[TBL] [Abstract][Full Text] [Related]
20. An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates.
Stimson WH; McAdam A; Hutchison RS
J Clin Lab Immunol; 1981 Mar; 5(2):129-31. PubMed ID: 7012357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
